Literature DB >> 21527610

Evaluation of hepatocellular carcinoma by contrast-enhanced sonography: correlation with pathologic differentiation.

Jin Feng Xu1, Hui Yu Liu, Yang Shi, Zhang Hong Wei, Ying Wu.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether contrast-enhanced sonography can be used to differentiate histopathologic grades of hepatocellular carcinoma.
METHODS: This study included 54 patients with hepatocellular carcinomas. All patients underwent fundamental and contrast-enhanced sonographic examinations. Auto-tracking contrast quantification software was used to determine the contrast arrival time, time to peak, peak intensity, contrast-enhanced time, wash-out time, enhancement slope, and clearance slope of the lesions. All lesions were confirmed by surgery. The hepatocellular carcinoma lesions were divided into 2 groups according to the World Health Organization grading system: group 1 (well-differentiated hepatocellular carcinomas) and group 2 (moderately to poorly differentiated carcinomas). The enhancement parameters between the groups were compared using a Student t test.
RESULTS: Fourteen of 20 well-differentiated lesions showed a "fast-in, slow-out" enhancement pattern, whereas 6 showed a "fast-in, fast-out" pattern. Thirty-three of 34 moderately to poorly differentiated lesions showed a fast-in, fast-out pattern, whereas only 1 showed a fast-in, slow-out pattern. The differences in the time to peak, contrast-enhanced time, wash-out time, enhancement slope, and clearance slope between the groups were statistically significant (P < .05), whereas the differences in the arrival time and peak intensity were not significant (P > .05).
CONCLUSIONS: The contrast patterns of well-differentiated and moderately to poorly differentiated hepatocellular carcinomas were quite different on contrast-enhanced sonography. The time to peak, contrast-enhanced time, and wash-out time of the well-differentiated hepatocellular carcinomas were longer than those of the moderately to poorly differentiated carcinomas, whereas the enhancement slope and clearance slope of the well-differentiated lesions were lower those that of the moderately to poorly differentiated lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527610     DOI: 10.7863/jum.2011.30.5.625

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  6 in total

Review 1.  Clinical implications of basic research in hepatocellular carcinoma.

Authors:  Renumathy Dhanasekaran; Sudhakar K Venkatesh; Michael S Torbenson; Lewis R Roberts
Journal:  J Hepatol       Date:  2015-10-09       Impact factor: 25.083

2.  Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma.

Authors:  Sandeep Moudgil; Naveen Kalra; Nidhi Prabhakar; Radha Krishan Dhiman; Arunanshu Behera; Yogesh Kumar Chawla; Niranjan Khandelwal
Journal:  J Clin Exp Hepatol       Date:  2017-03-16

Review 3.  Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma.

Authors:  C G Cristea; I A Gheonea; L D Săndulescu; D I Gheonea; T Ciurea; M R Purcarea
Journal:  J Med Life       Date:  2015 Apr-Jun

Review 4.  CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?

Authors:  Cosmin Caraiani; Bianca Boca; Vlad Bura; Zeno Sparchez; Yi Dong; Christoph Dietrich
Journal:  Biology (Basel)       Date:  2021-05-06

5.  Perfluorobutane contrast-enhanced ultrasonography: a new standard for ultrasonography-guided thermal ablation of sonographically occult liver tumours?

Authors:  Haiyuan Shi; Yi-Ting Ong; Apoorva Gogna; Nanda Venkatanarasimha; Sarat Kumar Sanamandra; Sum Leong; Farah Gillan Irani; Richard Hoau Gong Lo; Chow Wei Too
Journal:  Singapore Med J       Date:  2020-04-17       Impact factor: 1.858

6.  Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience.

Authors:  Adriana Ciocalteu; Sevastita Iordache; Sergiu Marian Cazacu; Cristiana Marinela Urhut; Sarmis Marian Sandulescu; Ana-Maria Ciurea; Adrian Saftoiu; Larisa Daniela Sandulescu
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.